Comparison of oral etoposide and standard intravenous multidrug chemotherapy for small-cell lung cancer: a stopped multicentre randomised trial

WHO Handbook for Reporting Results of Cancer Treatment

M K Palmer · British Journal of Cancer · 1982 · 2.2K citations · Full text

Medicine, Oncology, Cancer Control +11

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.

M L Slevin, Peter Clark, S P Joel et al. · Journal of Clinical Oncology · 1989 · 464 citations

Medicine, Oncology, Pharmacology +14

An overview of prognostic factors in small cell lung cancer

J Peto · British Journal of Cancer · 1990 · 205 citations · Full text

Medicine, Cancer Biology, Oncology +14

Bioavailability of low-dose oral etoposide.

Kenneth R. Hande, Mary G. Krozely, F. Anthony Greco et al. · Journal of Clinical Oncology · 1993 · 145 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Schedule dependency of 21-day oral versus 3-day intravenous etoposide in combination with intravenous cisplatin in extensive-stage small-cell lung cancer: a randomized phase III study of the Cancer and Leukemia Group B.

Antonius A. Miller, James E. Herndon, Donna Hollis et al. · Journal of Clinical Oncology · 1995 · 106 citations

Medicine, Oncology, Pharmacology +13